Keymed Biosciences Inventory

Keymed Biosciences (2162.HK) currently reports a inventory of $230M as of June 2026. That compares with $170M in the prior-year period — up 36.1% year over year. Use the charts on this page to explore Keymed Biosciences's inventory history and peer comparisons.

Keymed Biosciences's inventory increased from $170M to $230M — a 36.1% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Keymed Biosciences reported $230M in inventory as of June 2026. That compares with $170M in the prior-year period — up 36.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $230M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Keymed Biosciences, and consider following 2162.HK for alerts when major investors trade the stock.

Keymed Biosciences is classified in the Healthcare sector. On inventory, it currently shows $230M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 2162.HK with unrelated industries.